Christopher Weber to Janus Kinase Inhibitors
This is a "connection" page, showing publications Christopher Weber has written about Janus Kinase Inhibitors.
Connection Strength
0.161
-
The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis. Mucosal Immunol. 2018 09; 11(5):1454-1465.
Score: 0.161
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.